China's largest army hospital signed an agreement on Saturday
with U.S. drug maker Wyeth to set up a research center for clinical
drugs.
According to the agreement, General Hospital of People's
Liberation Army of China and Wyeth conduct trials on drugs that
will be used to treat dementia, schizophrenia, asthma and several
kinds of cancer.
"The agreement will enhance the research efficiency of clinical
drugs, cut costs, and allow patients to have more timely treatment
of new drugs," said Qin Yinhe, president of the army hospital.
"We will also explore new ways to produce and research new
drugs," said Qin.
Dr. Robert Maguire, chief of operations for clinical development
at Wyeth Research, said the agreement is an important part of
Wyeth's research and he hopes more Chinese patients will
benefit.
(Xinhua News Agency June 18, 2007)